Skip to main content

Advertisement

SpringerLink
Log in

Juvenile dermatomyositis: a tertiary center experience

  • Original Article
  • Published:
Clinical Rheumatology Aims and scope Submit manuscript

Abstract

Juvenile dermatomyositis (JDM) is a rare chronic inflammatory disease of unknown etiology and primarily involves muscle and skin. It is the most common idiopathic inflammatory myopathy of childhood. This study aimed to evaluate demographic and clinical features, laboratory data, treatment modalities, and outcome of patients with JDM at a referral pediatric rheumatology center in Turkey. We retrospectively reviewed medical records of patients diagnosed with JDM between the years 2003–2016 at the Pediatric Rheumatology Department Cerrahpasa Medical Faculty. A total of 50 patients (35 females), median age at the onset 6.1 ± 4.1 years, were identified. Mean follow-up period was 74.5 ± 49.7 months. Presenting clinical symptoms included heliotrope rash (100%), Gottron papule (96%), muscle weakness (90%), erythroderma (88%), and calcinosis (38%). All patients had elevated muscle enzymes at the disease onset. Sixty-eight percent of the patients had anti-nuclear antibody positivity. Electromyography on 27 patients and muscle biopsy on 14 patients were performed, and all of them showed signs of juvenile dermatomyositis. Early aggressive treatment with corticosteroids mostly in combination with methotrexate was used. Cyclosporine was added to 48% of the patients’ treatment regimen in case of severe or refractory disease. All patients except two cases, who were referred to our clinic after long disease duration with widespread calcinosis, achieved remission. Early diagnosis and early initiation of intensive therapy are important in reducing JDM complications. International collaboration is needed in order to better understanding and management of the disease.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Huber A, Feldman BM (2013) An update on inflammatory myositis in children. Curr Opin Rheumatol 25:630–635

    Article  CAS  PubMed  Google Scholar 

  2. Rider LG, Lindsley CB, Miller FW (2016) Juvenile Dermatomyositis. In: Petty RE, Laxer RM, Lindsley CB, Wedderburn L (eds) Textbook of pediatric rheumatology, 7th edn. Elsevier, Philadelphia, pp 351–383

    Chapter  Google Scholar 

  3. Rider LG, Katz JD, Jones OY (2013) Developments in the classification and treatment of the juvenile idiopathic inflammatory myopathies. Rheum Dis Clin N Am 39:877–904

    Article  Google Scholar 

  4. Symmons DP, Sills JA, Davis SM (1995) The incidence of juvenile dermatomyositis: results from a nation-wide study. Br J Rheumatol 34:732–736

    Article  CAS  PubMed  Google Scholar 

  5. Mendez EP, Lipton R, Ramsey-Goldman R, Roettcher P, Bowyer S, Dyer A, Pachman LM (2003) US incidence of juvenile dermatomyositis, 1995–1998: results from the National Institute of Arthritis and Musculoskeletal and Skin Diseases registry. Arthritis Rheum 49:300–305

    Article  PubMed  Google Scholar 

  6. Batthish M, Feldman BM (2011) Juvenile Dermatomyositis. Curr Rheumatol Rep 13:216–224

    Article  PubMed  Google Scholar 

  7. Shah M, Mamyrova G, Targoff IN, Huber AM, Malley JD, Rice MM, Miller FW, Rider LG (2013) The clinical phenotypes of the juvenile idiopathic inflammatory myopathies. Medicine (Baltimore) 92:25–41

    Article  CAS  Google Scholar 

  8. Ramanan AV, Feldman BM (2002) Clinical features and outcomes of juvenile dermatomyositis and other childhood onset myositis syndromes. Rheum Dis Clin N Am 28:833–857

    Article  CAS  Google Scholar 

  9. Morris P, Dare J (2010) Juvenile dermatomyositis as a paraneoplastic phenomenon: an update. J Pediatr Hematol Oncol 32:189–191

    Article  PubMed  Google Scholar 

  10. Bohan A, Peter JB (1975) Polymyositis and dermatomyositis (first of two parts). N Engl J Med 292:344–347

    Article  CAS  PubMed  Google Scholar 

  11. Bohan A, Peter JB (1975) Polymyositis and dermatomyositis (second of two parts). N Engl J Med 292:403–407

    Article  CAS  PubMed  Google Scholar 

  12. Robinson AB, Hoeltzel MF, Wahezi DM, Becker ML, Kessler EA, Schmeling H et al (2013) Clinical characteristics of children with juvenile dermatomyositis: the childhood arthritis and rheumatology research alliance (CARRA) registry. Arthritis Care Res 66:404–410

    Article  Google Scholar 

  13. Brown VE, Pilkington CA, Feldman BM, Davidson JE (2006) An international consensus survey of the diagnostic criteria for juvenile dermatomyositis (JDM). Rheumatology (Oxford) 45:990–993

    Article  CAS  Google Scholar 

  14. Gowdie PJ, Allen RC, Kornberg AJ, Akikusa JD (2013) Clinical features and disease course of patients with juvenile dermatomyositis. Int J Rheum Dis 16:561–567

    Article  CAS  PubMed  Google Scholar 

  15. Martin N, Li CK, Wedderburn LR (2012) Juvenile dermatomyositis: new insights and new treatment strategies. The Adv Musculoskelet Dis 4:41–50

    Article  CAS  Google Scholar 

  16. Ernste FC, Reed AM (2013) Idiopathic inflammatory myopathies: current trends in pathogenesis, clinical features, and up-to-date treatment recommendations. Mayo Clin Proc 88:83–105

    Article  PubMed  Google Scholar 

  17. Carstens PO, Schmidt J (2014) Diagnosis, pathogenesis and treatment of myositis: recent advances. Clin Exp Immunol 175:349–358

    Article  PubMed  PubMed Central  Google Scholar 

  18. Hashkes PJ, Wright BM, Lauer MS, Worley SE, Tang AS, Roettcher PA, Bowyer SL (2010) Mortality outcomes in pediatric rheumatology in the US. Arthritis Rheum 62:599–608

    PubMed  Google Scholar 

  19. Lazarevic D, Pistorio A, Palmisani E, Miettunen P, Ravelli A, Pilkington C et al (2013) The PRINTO criteria for clinically inactive disease in juvenile dermatomyositis. Ann Rheum Dis 72:686–693

    Article  CAS  PubMed  Google Scholar 

  20. Malek A, Raeeskarami SR, Ziaee V, Aghighi Y, Moradinejad MH (2014) Clinical course and outcomes of Iranian children with juvenile dermatomyositis and polymyositis. Clin Rheumatol 33:1113–1118

    Article  PubMed  Google Scholar 

  21. Ruperto N, Pistorio A, Oliveira S, Zulian F, Cuttica R, Ravelli A et al (2016) Prednisone versus prednisone plus cyclosporine versus prednisone plus methotrexate in new-onset juvenile dermatomyositis: a randomised trial. Lancet 387:671–678

  22. Faller G, Mistry BJ, Tikly M (2014) Juvenile dermatomyositis in South African child is characterized by frequent dystrophic calcification: a cross sectional study. Pediatr Rheumatol Online J 12:2

    Article  PubMed  PubMed Central  Google Scholar 

  23. McCann LJ, Juggins AD, Maillard SM, Wedderburn LR, Davidson JE, Murray KJ, Pilkington CA (2006) The Juvenile Dermatomyositis National Registry and Repository (UK and Ireland)—clinical characteristics of children recruited within 5 yr. Rheumatology (Oxford) 45:1255–1260

    Article  CAS  Google Scholar 

  24. Ravelli A, Trail L, Ferrari C, Ruperto N, Pistorio A, Pilkington C et al (2010) Long term outcome and prognostic factors of juvenile dermatomyositis: a multinational, multicenter study of 490 patients. Arthritis Care Res (Hoboken) 62:63–72

    Article  Google Scholar 

  25. Prasad S, Misra R, Agarwal V (2013) Juvenile dermatomyositis at a tertiary care hospital: is there any change in the last decade? Int J Rheum Dis 16:556–560

    Article  PubMed  Google Scholar 

  26. Saini I, Kalaivani M, Kabra SK (2016) Calcinosis in juvenile dermatomyositis: frequency, risk factors and outcome. Rheumatol Int 36:961–965

    Article  CAS  PubMed  Google Scholar 

  27. Kishi T, Miyamae T, Hara R, Nakajima S, Imagawa T, Mori M, Yokota S (2013) Clinical analyses of 50 children with juvenile dermatomyositis. Mod Rheumatol 23:311–317

    Article  PubMed  Google Scholar 

  28. Kim S, El-Hallak M, Dedeoglu F, Zurakowski D, Fuhlbrigge RC, Sundel RP (2009) Complete and sustained remission of juvenile dermatomyositis resulting from aggressive treatment. Arthritis Rheum 60:1825–1830

    Article  PubMed  PubMed Central  Google Scholar 

  29. Estruch R, Grau JM, Fernandez-Sola J, Casademont J, Monforte R, Urbano-Marquez A (1992) Microvascular changes in skeletal muscle in idiopathic inflammatory myopathy. Hum Pathol 23:888–895

    Article  CAS  PubMed  Google Scholar 

  30. Dorph C, Englund P, Nennesmo I, Lundberg IE (2006) Signs of inflammation in both symptomatic and asymptomatic muscles from patients with polymyositis and dermatomyositis. Ann Rheum Dis 65:1565–1571

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  31. Gitiaux C, De Antonio M, Aouizerate J, Gherardi RK, Guilbert T, Barnerias C et al (2016) Vaculopathy-related clinical and pathological features are associated with severe juvenile dermatomyositis. Rheumatology (Oxford) 55:470–479

    Google Scholar 

  32. Kolasinski SL, Chi AS, Lopez-Garib AJ (2016) Current perspectives on imaging for systemic lupus erythematosus, systemic sclerosis, and dermatomyositis/polymyositis. Rheum Dis Clin N Am 42:711–732

    Article  Google Scholar 

  33. Elessawy SS, Abdelsalam EM, Abdel Razek E, Tharwat S (2016) Whole-body MRI for full assessment and characterization of diffuse inflammatory myopathy. Acta Radiol Open 5:2058460116668216 eCollection 2016

    PubMed  PubMed Central  Google Scholar 

  34. Enders FB, Bader-Meunier B, Baildam E, Constantin T, Dolezalova P, Feldman BM et al (2016) Consensus-based recommendations for the management of juvenile dermatomyositis. Ann Rheum Dis. doi:10.1136/annrheumdis-2016-209247 [Epub ahead of print]

    PubMed  Google Scholar 

  35. Aggarwal R, Loganathan P, Koontz D, Qi Z, Reed AM, Oddis CV (2016) Cutaneous improvement in refractory adult and juvenile dermatomyositis after treatment with rituximab. Rheumatology (Oxford). Nov 11. pii: kew396. [Epub ahead of print]

Download references

Author information

Authors and Affiliations

  1. Department of Pediatric Rheumatology, Cerrahpasa Medical School, Istanbul University, Istanbul, Turkey

    Kenan Barut, Pinar Ozge Avar Aydin, Amra Adrovic, Sezgin Sahin & Ozgur Kasapcopur

Authors
  1. Kenan Barut
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Pinar Ozge Avar Aydin
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Amra Adrovic
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Sezgin Sahin
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Ozgur Kasapcopur
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ozgur Kasapcopur.

Ethics declarations

Disclosures

None.

Electronic supplementary material

Supplementary file 1

The treatment algorithm of our clinic for Juvenile dermatomyositis (DOCX 38 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Barut, K., Aydin, P.O.A., Adrovic, A. et al. Juvenile dermatomyositis: a tertiary center experience. Clin Rheumatol 36, 361–366 (2017). https://doi.org/10.1007/s10067-016-3530-4

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10067-016-3530-4

Keywords

Search

Navigation